| Research in Nuclear Medicine |
| Research in the department focuses mainly on clinical studies, with the overall aims of improving clinical care and management of patients. |
| |
| |
| (1) Randomised trial of adjuvant hepatic intra-arterial iodine-131-lipoidal following curative resection of hepatocellular carcinoma. |
|
| Principle Investigator(s) or Collaborator(s) |
: |
Dr Ong Seng Chuan, Dr Anthony Goh Soon Whatt
| |
| |
| (2) An open label, phase IIa, safety study of the active implantable (radiological) medical device 32P BioSiliconTM, administered intratumourally to patients with advanced, unresectable pancreatic cancer, in addition to standard intravenous gemcitabine chemotherapy. |
|
|
| Principal Investigator(s) or Collaborator(s) |
: |
Dr Anthony Goh, Dr David Ng, Mr Somanesan S, Mr Hoi Kong Meng
| |
| |
| (3) Phase II study for the use of iodine-131 conjugated anti-CD20 monoclonal antibody in patients with relapsed or refractory low-grade, transformed low, intermediate and high-grade B-cell non-Hodgkin's lymphoma. |
|
| Principal Investigator(s) or Collaborator(s) |
: |
Dr David Ng | |
| |
| (4) Prospective evaluation of the role of fluorine-18 fluorodeoxyglucose intergrated positron emission tomography/ computed tomography (PET/ CT) imaging for the primary staging of nasopharyngeal cancer. |
|
| Principal Investigator(s) or Collaborator(s) |
: |
Dr Ong Seng Chuan, Dr David Ng, Dr Anthony Goh | |
| |
| (5) Structural and Functional imaging in Refractory Focal Epilepsy |
|
| Principal Investigator(s) or Collaborator(s) |
: |
Dr David Ng, Dr Anthony Goh | |
| |
|
|
| |
|
| |
| |
|